Cilazapril
|
|
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (February 2011) |
| Cilazapril | |
|---|---|
|
9-[(1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino]-10-oxo-octahydro-1H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid[citation needed] |
|
| Identifiers | |
| CAS number | 88768-40-5 (1S,9S)-9-[(2S)-2-yl]amin,-1-carbox |
| PubChem | 2751, 40467985 (1R,9S)-9-[(2S)-2-yl]amin,-1-carbox, 56330 (1S,9S)-9-[(2S)-2-yl]amin,-1-carbox |
| ChemSpider | 2649 |
| UNII | 8Q9454114Q |
| DrugBank | DB01340 |
| KEGG | D07699 |
| ChEMBL | CHEMBL515606 |
| ATC code | C09 |
| Jmol-3D images | Image 1 |
|
|
|
|
| Properties | |
| Molecular formula | C22H31N3O5 |
| Molar mass | 417.5 g mol−1 |
| Exact mass | 417.226371117 g mol-1 |
| log P | 2.212 |
| Acidity (pKa) | 2.285 |
| Basicity (pKb) | 11.712 |
| Pharmacology | |
| Routes of administration |
Oral |
| Legal status |
POM(UK) |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
| Infobox references | |
Cilazapril is a pyridazine angiotensin-converting enzyme inhibitor (ACE inhibitor) used for the treatment of hypertension and congestive heart failure. It is branded as Inhibace in Canada, Zapril in New Zealand, Vascace and Dynorm in Europe. According to drugs.com (who have a partnership with the US Food & drug Administration) none of these are currently available in the United States as of May 2010.
Several stereo isomers exist of which, only one isomer is medically viable: cilazapril ((1S,9S)-9-[(2S)-2-yl]amin,-1-carbox)
[edit] References
- Cilazapril monograph. Lexi-Comp Online, Lexi-Drugs Online, Lexi-Comp Inc. Hudson, OH. Available at: [1]. Accessed October 5th, 2008.
|
||||||||||||||||
| This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |